Aylin
Aylin Azmin, Vancouver CA
Patent application number | Description | Published |
---|---|---|
20150078653 | METHOD AND APPARATUS FOR PERFORMING A FRAGMENTATION ASSESSMENT OF A MATERIAL - A method and apparatus for performing a fragmentation assessment of a material including fragmented material portions is disclosed. The method involves receiving two-dimensional image data representing a region of interest of the material, and processing the 2D image data to identify features of the fragmented material portions. The method also involves receiving a plurality of three dimensional point locations on surfaces of the fragmented material portions within the region of interest, identifying 3D point locations within the plurality of three dimensional point locations that correspond to identified features in the 2D image, and using the identified corresponding 3D point locations to determine dimensional attributes of the fragmented material portions. | 03-19-2015 |
Aylin Cimenser, Cambridge, MA US
Patent application number | Description | Published |
---|---|---|
20140187973 | SYSTEM AND METHOD FOR TRACKING BRAIN STATES DURING ADMINISTRATION OF ANESTHESIA - A method and system for determining the state of a patients brain under anesthesia. The present invention recognizes that anesthesia compounds induce different signatures in physiological characteristics of the patient under anesthesia and aids interpretation of physiological characteristics and signatures therein based on a selected anesthesia compound. The present invention aids the monitoring and/or interpreting of the physiological characteristics to a state of the patient's brain. | 07-03-2014 |
Aylin Kim, Seattle, WA US
Patent application number | Description | Published |
---|---|---|
20130190571 | SURGICAL TISSUE PROTECTION SHEATH - A surgical sheath for use in endoscopic trans-nasal or intra-ocular surgery has an angle section joined to a conical section, with the conical section having a central axis not parallel to a central axis of the angle section. A body section is joined to the angle section, with the body section having a length at least twice the length of the angle section. The conical section, the angle section and the body section may be a flexible or compliant material. The sheath reduces collateral trauma to the tissues in the surgical pathway. | 07-25-2013 |
Aylin Koegler, Rowville AU
Patent application number | Description | Published |
---|---|---|
20150140660 | HYDROGEN CYANIDE-BASED POLYMER SURFACE COATINGS AND HYDROGELS - The present invention provides a process of coating at least a portion of a substrate surface comprising contacting the surface with hydrogen cyanide monomeric units under conditions permitting polymerisation of the hydrogen cyanide monomeric units to form a polymer that coats the surface. Also provided is a substrate coated by a polymer according to the claimed process. Also provided is a method of forming a hydrocyanic acid-based hydrogel, the method comprising co-polymerisation in a solution, the solution comprising hydrogen cyanide monomer units and co-monomers. | 05-21-2015 |
Aylin Met, Istanbul TR
Patent application number | Description | Published |
---|---|---|
20140298836 | Cooling Device Comprising a Storage Tank Wherein the Liquid Stored Therein is Sterilized - The present invention relates to a cooling device ( | 10-09-2014 |
Aylin Ozdemir Bahadir, Gebze TR
Patent application number | Description | Published |
---|---|---|
20140199301 | RECOMBINANT ANTIBODY STRUCTURES BINDING TO AND BLOCKING THE ACTIVITY OF VASCULAR ENDOTHELIAL GROWTH FACTOR 2 (VEGFR- 2/KDR) - Phage displayed recombinant antibody library was developed and the library was screened against VEGFR-2. After screening and ELISA experiments two recombinant antibodies showing binding properties to VEGFR-2 was obtained. The difference of the two recombinant antibodies to the recombinant antibodies already developed was demonstrated by DNA sequence analysis. The inhibition effect of the two recombinant antibodies on endothelial cell proliferation was demonstrated with cell assays. Thus these recombinant antibodies might be used as VEGF related angiogenesis inhibitors. | 07-17-2014 |